...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Circulation journal >Therapeutic Strategy for Gastrointestinal Bleeding in Patients With Left Ventricular Assist Device
【24h】

Therapeutic Strategy for Gastrointestinal Bleeding in Patients With Left Ventricular Assist Device

机译：左心室辅助装置患者胃肠道出血的治疗策略

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Left ventricular assist device (LVAD) technology has improved the survival of advanced heart failure patients. However, readmission rates following LVAD implantation remain high and are an unsolved matter. Currently, gastrointestinal bleeding is one of the major causes of readmission and has recently been demonstrated to mainly result from increased angiogenesis. In addition to the conventional therapeutic strategies, including a reduction in antiplatelet and anticoagulation therapies and blood products administration, several therapeutic tools have recently been proposed: octreotide, thalidomide, hemodynamic optimization by the ramp test, and fish oil therapy. This review will update the therapeutic strategy for gastrointestinal bleeding in LVAD patients.
机译：左心室辅助装置（LVAD）技术提高了晚期心力衰竭患者的生存率。但是，LVAD植入后的再入院率仍然很高，并且尚未解决。当前，胃肠道出血是再入院的主要原因之一，近来已证明主要是由于血管新生增加所致。除了常规的治疗策略，包括减少抗血小板和抗凝治疗以及血液制品的给药外，最近还提出了几种治疗工具：奥曲肽，沙利度胺，通过斜坡试验的血液动力学优化和鱼油疗法。这篇综述将更新LVAD患者胃肠道出血的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号